Aligos Therapeutics, Inc. (ALGS) Earnings
NASDAQ·Healthcare·Biotechnology
$6.31
-1.87%
Mkt Cap $43.23M
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
-$2.29
3 analysts
Revenue Estimate
$250.00K
Last quarter: beat by +23.19% on EPS, -61.59% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$43.23M
P/E
—
Fwd P/E
—
P/S
17.80
Rev TTM
—
EPS TTM
-$2.33